Clinical Trial

Comparison of Intrathecal Morphine and Rectus Sheath Block for Postoperative Pain Management After Lower Abdominal Surgery With Midline Incision

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 30, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the efficacy of intrathecal morphine and rectus sheath block compared with standard postoperative analgesia for pain management in patients undergoing lower abdominal surgery with a midline incision. Effective postoperative analgesia is essential to enhance recovery, reduce opioid consumption, and improve overall patient comfort. In this prospective randomized controlled trial, eligible patients scheduled for lower abdominal surgery through a midline incision will be randomly assigned to one of three groups: intrathecal morphine, rectus sheath block, or control (standard postoperative analgesia without regional intervention). Postoperative outcomes will include pain scores, quality of recovery (QoR) scores, functional recovery parameters, patient satisfaction, incidence of postoperative nausea and vomiting, and rescue analgesic requirements. The findings of this study may provide evidence on the comparative effectiveness of these analgesic strategies and contribute to the development of optimized multimodal pain management protocols in lower abdominal surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-18.
Trial Details
NCT Number NCT07489872
Lead Sponsor Marmara University
Conditions Postoperative Analgesia, Pain Management
Enrollment 66 participants
Start Date 2025-02-24
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-30